Why the study?
Evidence on surgical correction of SMR is sparse and trials of transcatheter repair have yielded conflicting results, requiring updated practical management guidance.
Answers are grounded in this paper and cite their sources.
This joint position statement outlines a multidisciplinary Heart Team approach for the evaluation and management of secondary mitral regurgitation in heart failure.
Secondary (or functional) mitral regurgitation (SMR) occurs frequently in chronic heart failure (HF) with reduced left ventricular (LV) ejection fraction, resulting from LV remodelling that prevents coaptation of the valve leaflets. Secondary mitral regurgitation contributes to progression of the symptoms and signs of HF and confers worse prognosis. The management of HF patients with SMR is complex and requires timely referral to a multidisciplinary Heart Team. Optimization of pharmacological and device therapy according to guideline recommendations is crucial. Further management requires careful clinical and imaging assessment, addressing the anatomical and functional features of the mitral valve and left ventricle, overall HF status, and relevant comorbidities. Evidence concerning surgical correction of SMR is sparse and it is doubtful whether this approach improves prognosis. Transcatheter repair has emerged as a promising alternative, but the conflicting results of current randomized trials require careful interpretation. This collaborative position statement, developed by four key associations of the European Society of Cardiology-the Heart Failure Association (HFA), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association of Cardiovascular Imaging (EACVI), and European Heart Rhythm Association (EHRA)-presents an updated practical approach to the evaluation and management of patients with HF and SMR based upon a Heart Team approach.
No takes yet. Share an insight, caveat, or question.
Coats et al. (2021) conducted a review in Secondary mitral regurgitation in patients with heart failure. Multidisciplinary Heart Team management including guideline-directed medical therapy, cardiac resynchronization therapy, and transcatheter edge-to-edge mitral valve repair (MitraClip) vs. Guideline-directed medical therapy alone was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: